Concurrent chemoradiotherapy with paclitaxel and carboplatin for stage III or IVA cervical cancer with renal dysfunctio
Not Applicable
- Conditions
- ocally advanced stage III or IVA cervical cancer with renal dysfunction
- Registration Number
- JPRN-UMIN000026034
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
Patients treated with paclitaxel or carboplatin previously
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cancellation rate by adverse events
- Secondary Outcome Measures
Name Time Method